Summary: Renal inulin clearance remains the standard by which other methods of measuring glomerular filtration rate are judged. A fully automated enzymatic assay capable of use with linear configuration inulin was recently published (Summerfield AL, et al. Clin Chem 1993; 39:2333-7). Sinistrin, a readily soluble preparation of polyfructan with side branching, is more suitable for clinical use and far more widely used in Europe. By modifying the incubation phase of samples with inulinase, incorporating a kinetic modification to the method of fructose analysis, and increasing the buffer strengths, we report a fully automated system, with minimal sample prehandling capable of complete sinistrin hydrolysis, and adapted for use on the Cobas Mira.
Introduction
The measurement of inulin clearance as a marker of glomerular filtration rate provides the most accurate assessment of renal function. It is subject neither to extra renal metabolism, nor tubular handling, not bound by plasma proteins and capable of free passage through the glomerular basement membrane (1) .
Its clinical use has been restricted by several difficulties. Firstly, the insolubility of standard inulin (linear configuration (1,2-linked) polyfructan) renders its use for patient injection difficult. Secondly, the acid hydrolysis of inulin prior to assaying liberated fructose requires considerable laboratory time, especially when concentrated and corrosive reagents are used for the additional purpose of deproteination. Finally colorimetric determination of fructose is not specific (2) .
Recent modifications have incorporated the use of an enzymatic assay for fructose, either to the endpoint of substrate consumption, (using Bergmeyer's original combination of hexokinase, glucose-6-phosphate dehydrogenase and phosphoglucose isomerase) (3) or similar combinations (4) , or more suitable for automation a kinetic assay based on sorbitol dehydrogenase (5) 2 ).
The use of commercially available synergistic combination of exo-and endo-inulinases 2 ) has enabled a fully automated enzymatic assay (6) . Our own trials of this method worked well with linear configuration inulin, once adapted to employ a kinetic assay for fructose. This adaptation is more suitable to a reaction which results in a small free energy change, leaving a substantial quantity of substrate in equilibrium with product. This modification has also recently been reported by the same group (7).
Sinistrin is a branched polyfructan first reported by Schmeideberg in 1879 (see fig. 1 
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African root vegetable Red Squill, Urginea maritima. Its greater solubility allows far greater ease of handling and preparation for injection for clearance studies. Its degree of polymerisation, consequent relative molecular mass, and equivalent maximum radius from hydrodynamic studies (8) indicate a satisfactory permeability through the glomerular basement membrane, confirmed in subsequent clinical studies (9) .
Sinistrin has proved considerably less amendable to enzymatic cleavage than linear inulin, we report a fully automated method capable of complete sinistrin hydrolysis. 
Materials and Methods

Specimens
Plasma samples were taken as part of inulin infusion clearance examinations from healthy volunteers, its use has already been well described (10, 11) . This method of analysis of inulin clearance is more suitable in patients with normal or high glomerular filtration rates such as the diabetic hyperfiltering patients we are studying, being less prone to errors from delay to steady state inulin concentration, and delayed equilibration with muscle and fascial tissue compartments. It entails the administration of a bolus dose of sinistrin proportionate to volume of distribution, and a continuous infusion at a rate anticipated to bring the serum steady state concentration to a predetermined target, calculated from previous estimates of clearance. Two samples are taken from the contralateral arm of semirecumbent subjects 2 h after commencement of the infusion. Together with a sample of the infusate these are analysed
Methods
We adapted the previously described method (6) for use on a Cobas Mira (Roche Diagnostic Systems, Welwyn, UK), incorporating a 1250s predilution phase, a shorter path length for colorimetry, based on a kinetic analysis of the conversion of fructose to sorbitol, and two fructose standards for calibration with each run. The Mira programme is given in table 1.
Serum samples were stored at 4 °C for up to one week, or frozen and kept at -20 °C for up to 3 months. Urine and infusate samples were diluted twenty-fold in radioimmunoassay grade bovine serum albumin, 40 g/1 before the assay. When stored at 4 °C, sorbitol dehydrogenase retains its activity for 14 days and Novozym 230 was active for over 6 months.
The correlation coefficients were determined by Pearson's method.
The comparison of data on the assay of fructans and fructose were analysed by linear regression. Both were calculated using a Systat 5.02 statistics programme.
Results
Our initial experiments, based on the use of an endpoint determination of sorbitol generation, with an increased path length of 1250 seconds gave poor linearities above fructose concentrations of 250 mg/1 in prepared standards, despite substantial increases in sorbitol dehydrogenase concentration. By shortening the path length considerably and reducing the sorbitol dehydrogenase to examine a reaction velocity-related absorbance change, after Dalton & Turner (5), we were able to obtain linear results up to 400 mg/1 of fructose.
We found it necessary to augment the strength of the phosphate buffer to 500 mmol/1 in order to reliably bring the pH of serum samples after dilution to near the optimal range for Novozym's chief components, pH 4.7 (12). As a corollary, HEPES buffer also needed to be considerably stronger, to subsequently elevate the pH to optimal for sorbitol dehydrogenase, at 7.4 (13).
Having used linear configuration inulin as a source for standards we were able to corroborate (6) a full and linear recovery of fructose from inulin. Allowing for a 6% impurity by weight of water and non-reducing sugars (Sigma quote 2-4% water content at time of manufacture), we found r = 0.999, linear regression y = 0.98x + 2.35 mg/1, for standards from 0 to 400 mg/1 in bovine serum albumin. In the presence of 50 mmol glucose in the samples, this correlation and regression was identical.
However on changing the source of our polyfructan to sinistrin, we found a consistent recovery of only 56% of the equivalent weight of fructose. Prolonging the incubation time to minimum of two hours at room temperature was sufficient to release 107% of the equivalent weight of crystalline fructose, just short of the 111.1% appropriate to hexose hydrolysis.
After a variety of experiments with enzyme combinations capable of levanase activity (2,6-polyfructan hy-drolysis), we found that only a considerable excess of Novozym 230, was sufficient to maximally hydrolyse sinistrin in the desired preincubation time of 1250 s on the Mira. Comparison of our fructose yields by the assay with 24 h manual incubations of the same samples in plasma at 22 °C demonstrated near equivalent hydrolysis, y = 0.971x + 2.78 mg/1 (n = 70). This was unchanged by further increasing the incubation concentration of Novozym to 67.5 kU/1.
After these modifications, our recovery of fructose from sinistrin against fructose standards, as analysed by linear regression was y = 1.067x + 0.05 mg/1, r = 1.000, and in the presence of 54.3 mmol glucose standards, there appeared to be a minor effect on the greater concentrations of inulinase, y = 1.053x -1.13 mg/1, r = 1.000.
Interassay variation for whole clearance determination on the same set of samples was satisfactory, with CV at 4.4% (number of sample sets = 25, no of runs = 10). Following our prospectively determined practice of rejecting results with a greater than 10 mg/1 variation between any duplicate samples, the CV for repeated clearance determinations was 2.8% (n = 19). We have determined a range of infusion clearance values in 16 healthy volunteers of 112.9 (± standard deviation 16.8) ml/min, corrected for a surface area of 1.73 m 2 .
We confirmed that bovine serum albumin has a matrix effect in augmenting fructose recovery (6) . With our assay this amounted to an additional 9%. This appears to be attributable in part to the sorbitol dehydrogenase conversion of fructose, standards prepared in bovine serum albumin consistently showed a 6% greater absorbance change compared to those in deionised water.
Finally we found that exposure of serum samples to 62 °C for 5 min was sufficient to inactivate sorbitol dehydrogenase, for sample preparation for patients whose serum was likely to contain substantial quantities of it, theoretically capable of altering the kinetics of the reaction. This mainly pertains in hepatocellular disease. This brief heating did not precipitate plasma proteins or detectably hydrolyse sinistrin.
Discussion
Polyfructans are an abundant energy storage compound in plants, and the lack of a hydrolytic enzyme system in mammals render them ideal as inert markers of renal clearance. The levanbiose (levans being ß-2,6-linked polyfructans) side chains found in sinistrin augment the compound's solubility, but tender it considerably less susceptible to exo-and endo-inulinase attack. (14, 15) . Only more profligate varieties of exoinulinase, termed fructan ß-fructosidases (EC 3.2.1.80) have levanase activity (14) , and this seems to be an important discriminant in their classification. We found that a concentration 169 times greater than previously reported was necessary for maximal hydrolysis of sinistrin (6) , and that description employed a 100-fold greater concentration than had been found necessary for the complete liberation of fructose from linear inulin up to 300 mg/1. Additionally we were obliged to include a prolonged incubation time, and considerably stronger buffers to ensure optimal pH for hydrolytic activity.
These observations underline the importance of ensuring the extent of sinistrin hydrolysis in enzymatic assays. A decrement in yield from incomplete hydrolysis might not be apparent if sinistrin standards were used as calibrators. Furthermore a differential decrement in fructose yields from plasma as opposed to urine or infusate samples, arising from a failure to adequately lower pH in samples with a stronger intrinsic buffering system could entail serious miscalculations of clearance.
Preliminary work suggests a very similar performance for Novo's currently available inulinase preparation Fructozyme, derived from A. niger.
